AB

Mitochondrial Disorders - Comprehensive Notes

Mitochondrial Disorders

mtDNA Genome Contents

  • mtDNA contains genes for:
    • tRNAs
    • rRNAs
    • Cytochrome oxidase subunits
    • NADH-dehydrogenase subunits
    • ATPase subunits
  • mtDNA genes are located on both strands.
  • The functions of all human mtDNA Open Reading Frames (ORFs) are assigned.
  • Nuclear DNA also contains mitochondrial genetic information, including genes for:
    • DNA polymerase
    • Replication factors
    • RNA polymerase
    • Transcription factors
    • Ribosomal proteins
    • Translation factors
    • Aminoacyl-tRNA synthetase
    • Additional cytochrome oxidase, NADH, and ATPase subunits.
  • Most mitochondrial (and chloroplast) proteins are coded by nuclear genes.

Transcription of mtDNA

  • mRNAs from the mtDNA are synthesized and translated in the mitochondria.
  • Gene products encoded by nuclear genes are transported from the cytoplasm to the mitochondria.
  • Mammalian and vertebrate mtDNAs are transcribed as a single large RNA molecule (polycistronic) which is then cleaved to produce mRNAs, tRNAs, and rRNAs before processing.
  • Most mtDNA genes are separated by tRNAs that signal transcription termination.

Translation of mtDNA

  • Mitochondria mRNAs do not have a 5' cap (yeast and plant mt mRNAs have a leader sequence).
  • Specialized mtDNA-specific initiation factors (IFs), elongation factors (EFs), and release factors (RFs) are utilized for translation.
  • AUG is the start codon (binds with fMet-tRNA like bacteria).

Mitochondria & Oxidative Phosphorylation

  • Oxidative phosphorylation (OXPHOS) involves several complexes (I-V) located in the inner mitochondrial membrane.
  • These complexes facilitate the transfer of electrons and protons, generating ATP.
  • Complex I: NADH dehydrogenase
  • Complex II: Succinate dehydrogenase
  • Complex III: Cytochrome bc1 complex
  • Complex IV: Cytochrome c oxidase
  • Complex V: ATP synthase.
  • The process involves the TCA cycle (carbohydrate metabolism) and beta-oxidation (fatty acid metabolism) which feeds into the OXPHOS complexes.

Mitochondrial Genome

  • The mitochondrial genome is a circular chromosome of 16.6 kb.
  • Most cells contain at least 1000 mtDNA molecules distributed among hundreds of individual mitochondria.
  • Mature oocytes have more than 100,000 copies of mtDNA.

mtDNA Composition

  • 16.6 kb in size (compared to 3 billion in the nuclear genome).
  • Contains 37 genes:
    • 22 tRNAs
    • 2 rRNAs
    • 13 proteins (all subunits of the electron transport chain (ETC)).
  • mtDNA is entirely devoted to energy metabolism.

Human Mitochondrial Genome

  • Key genes include 12S rRNA, 16S rRNA, Cytochrome b (Cyt b), and genes encoding NADH dehydrogenase subunits (ND1-ND6, ND4L), Cytochrome Oxidase subunits (COI, COII, COIII), and ATPase subunits (ATPase6, ATPase8).
  • Mutations in these genes can cause diseases such as Leber Hereditary Optic Neuropathy (LHON) and Myoclonic Epilepsy with Ragged Red Fibers (MERRF).
  • Control region of mtDNA includes the D-loop.

Mitochondrial Diseases

  • Different rearrangements and point mutations identified in mtDNA can cause human disease, often involving the central nervous and musculoskeletal systems (e.g., myoclonic epilepsy with ragged-red fibers- MERRF).
  • Mitochondrial diseases have a distinctive pattern of inheritance due to three unusual features of mitochondria: replicative segregation, homoplasmy and heteroplasmy, and maternal inheritance.

Replicative Segregation

  • Absence of tightly controlled segregation.
  • At cell division, multiple copies of mtDNA in each mitochondrion replicate and sort randomly among newly synthesized mitochondria.
  • Mitochondria are distributed randomly between the two daughter cells.
  • This process is known as replicative segregation.

Mutant mtDNA

  • When a mutation arises in the mtDNA, it is initially present in only one mtDNA molecule within a mitochondrion.
  • Through replicative segregation, a mitochondrion containing a mutant mtDNA will acquire multiple copies of the mutant molecule.
  • With cell division, a cell containing a mixture of normal and mutant mtDNAs can distribute varying proportions of mutant and wild-type mitochondrial DNA to its daughter cells.

Homoplasmy and Heteroplasmy

  • One daughter cell may receive mitochondria containing only a pure population of normal mtDNA or a pure population of mutant mtDNA (homoplasmy).
  • Alternatively, the daughter cell may receive a mixture of mitochondria, some with and some without mutation (heteroplasmy).
  • The phenotypic expression of a mutation in mtDNA depends on the relative proportions of normal and mutant mtDNA in the cells making up different tissues, leading to reduced penetrance, variable expression, and pleiotropy.

Maternal Inheritance

  • Nuclear DNA is inherited from all ancestors, while mitochondrial DNA is inherited from a single maternal lineage.
  • Sperm mitochondria are generally eliminated from the embryo, ensuring mtDNA is inherited from the mother.
  • Maternal inheritance in the presence of heteroplasmy is associated with additional features:
    • The number of mtDNA molecules within developing oocytes is reduced before being amplified to the quantities seen in mature oocytes. This is the mitochondrial genetic bottleneck.

Mutant mtDNA and Offspring

  • Mothers with a high proportion of mutant mtDNA molecules are more likely to produce eggs with a higher proportion of mutant mtDNA and are therefore more likely to have clinically affected offspring.
  • An exception occurs when the mother is heteroplasmic for a deletion mutation in her mtDNA; deleted mtDNA molecules are generally not transmitted to their children.

Leber Hereditary Optic Neuropathy (LHON)

  • Pedigree shows maternal inheritance.

Examples of Mitochondrial Diseases

  • MELAS (Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like episodes)
  • MERRF (Myoclonic Epilepsy with Ragged Red Fibres)
  • Leber Hereditary Optic Neuropathy (LHON)
  • External Ophthalmoplegia
  • Kearns-Sayre syndrome
  • Chronic progressive external ophthalmoplegia
  • NARP (Neurogenic weakness Ataxia with Retinitis Pigmentosa)

Specific Disease Examples

  • MELAS: Associated with tRNALeu mutation [MTTL1*MELAS3243G].
  • MERRF: Associated with tRNALys mutation [MTTK*MERRF8344G].
  • LHON: Caused by mutations in ND1, ND2, ND4, ND5, ND6, CO1, ATP6, CO3, and CYTB genes.
  • Kearns-Sayre syndrome: Caused by a deletion of 4.9kb affecting the region between ATP8 and ND5.
  • NARP: Caused by ATP6 gene mutation.

Clinical Presentation of Mitochondrial Diseases

  • Tissues most highly dependent on ATP production are primarily affected:
    • Nerves
    • Muscles
    • Endocrine system
    • Kidney
  • Low energy-requiring tissues are rarely directly affected but may be secondarily:
    • Lung
    • Connective tissue
  • Symptoms can be intermittent:
    • Increased energy demand (illness, exercise)
    • Decreased energy supply (fasting)

Nuclear Encoded Mitochondrial Disease

  • Caused by mutations in genes coding for mitochondrial proteins that are transported to the mitochondria after expression.
  • These proteins have a signature localization sequence (~30 amino acids) that targets them to particular receptors on mitochondrial membranes.
  • After binding the receptor, these proteins are transported inside the mitochondria where they function in OX-PHOS, iron metabolism, mitochondrial DNA replication, and integrity.

Protein and Substrate Defects

  • Protein import defects: low levels of Pyruvate Dehydrogenase activity.
  • Substrate Transport Defects: affect fatty acid oxidation (e.g., CACT gene - carnitine-acylcarnitine translocase mutations affect transport of long-chain fatty acids).
  • Substrate utilization defects: Carnitine palmitoyl transferase (CPT2) mutations impair the oxidation of long-chain fatty acids.
  • Iron Transport Defects: Fredreich’s Ataxia is caused by a mutation in frataxin, leading to excess iron accumulation in the mitochondria.
  • Electron Transport Chain Defects: Mutations in genes coding enzymes that work in Complex I, II, and III of the OXPHOS system.

Characteristics of Human Mitochondrial Diseases

  • Are maternally inherited: only offspring of affected mothers are affected.
  • Show deficiency in mitochondrial function.
  • Are caused by a mutation in a mitochondrial gene.
  • Example: myoclonic epilepsy and ragged red fiber disease (MERRF).
  • Deafness, dementia, seizures can occur.
  • Result from point mutations in mitochondrial tRNA.

Optic Neuropathies

  • Include:
    • Leber hereditary optic neuropathy
    • Optic neuritis
    • Anterior ischaemic optic neuropathy (AION)
  • Specific types:
    • Retrobulbar neuritis
    • Papillitis
    • Neuroretinitis

Anatomy of the Optic Nerve

  • The optic nerve is the second of twelve paired cranial nerves but is considered part of the central nervous system.
  • Composed of retinal ganglion cell axons and Portort cells
  • Most axons of the optic nerve terminate in the lateral geniculate nucleus, relaying information to the visual cortex.
  • Its diameter increases from about 1.6 mm within the eye to 3.5 mm in the orbit and 4.5 mm within the cranial space.

Signs of Optic Nerve Dysfunction

  • Reduced visual acuity
  • Diminished light brightness sensitivity
  • Dyschromatopsia (color vision deficiency)
  • Afferent pupillary conduction defect

Visual Field Defects

  • Central scotoma
  • Centrocaecal scotoma
  • Papillomacular bundle defects
  • Altitudinal defects
  • Nerve fiber bundle defects

Optic Disc Changes

  • Retrobulbar neuritis - Normal.
  • Early compression.
  • Papilloedema - Swelling.
  • Papillitis and neuroretinitis - Swelling.
  • Optic nerve sheath meningioma - Optico-ciliary shunts.
  • Occasionally optic nerve glioma - Optico-ciliary shunts.
  • Postneuritic - Atrophy.
  • Compression - Atrophy.
  • AION - Atrophy.
  • Hereditary optic atrophies - Atrophy.

Special Investigations for Optic Nerve Issues

  • MRI with orbital fat-suppression techniques in T1-weighted images
  • Assessment of electrical activity of visual cortex created by retinal stimulation (Visually evoked potential)

Classification of Optic Neuritis

  • Retrobulbar neuritis (normal disc):
    • Demyelination (most common)
    • Sinus-related (ethmoiditis)
    • Lyme disease
  • Papillitis (hyperaemia and oedema):
    • Viral infections and immunization in children (bilateral)
    • Demyelination (uncommon)
    • Syphilis
  • Neuroretinitis (papillitis and macular star):
    • Cat-scratch fever
    • Lyme disease
    • Syphilis

Leber Hereditary Optic Neuropathy (LHON)

  • Degeneration of the retinal ganglion cells and their axons.
  • Asymptomatic until visual blurring develops.

Specific Mutations in LHON

  • Leber’s Hereditary Optic Neuropathy (LHON) – frequency ~1/30,000, making it the most common mitochondrial disease.
  • Bilateral loss of vision caused by degeneration of the optic nerve.
  • Susceptibility of retinal ganglion cells.
  • Specific mutations in genes encoding components of Complex I of the oxidative phosphorylation system.
  • Three most common primary mutations:
    • G11778A in ND4 gene (69%, most severe)
    • G3460A in ND1 gene (13%, less severe)
    • T14484C in ND6 gene (14%, least severe)
  • Other 5% are considered secondary mutations.

Penetrance and Modifying Factors in LHON

  • Penetrance is incomplete – 50-60% in males and 10-20% in females.
  • Factors influencing penetrance:
    • Mutational load, tissue distribution, and threshold effect: a threshold level of ~60% mutant mtDNA may be required.
    • mtDNA background - haplogroups.
    • Nuclear genes – likely to be X-linked.
    • Environmental factors – ?alcohol, tobacco.
  • General guidelines:
    • More mutant mtDNA; more likely to be penetrant!
    • More mutant mtDNA; more likely to be transmitted!

Specific Mutations and Syndromes

  • MILS (Maternally-Inherited Leigh Syndrome):
    • Progressive neurologic disease with motor and intellectual developmental delay.
    • Brainstem and/or basal ganglia disease.
    • Characteristic neuropathological features.
    • Onset 3-12 months, death by 2-3 years.
    • Associated with various mtDNA genes, including ATP6.
  • NARP (Neurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa):
    • Peripheral neuropathy.
    • Cerebral and cerebellar atrophy.
    • Variable ocular manifestations.
    • Later childhood or adult onset.
    • Mutations in ATP6 gene.

Intermediate Phenotypes

  • Any combination of NARP and MILS, along with other symptoms of mtDNA disease.
  • Specific mutations: m.8993T>G/C.

Mutations in ATPase Subunit 6 Gene (Complex V)

  • Common mutation in ATPase subunit 6 gene (complex V) – m.8993T>G or m.8993T>C.
  • Minimal tissue-dependent and age-dependent variation.
  • Phenotype predictability based on mutation load:
    • Up to 60% - unaffected.
    • 60-90% - NARP.
    • >90% - MILS.
  • MILS/NARP are multi-system disorders with a continuum of phenotypes dependent upon Mutational Load!

Specific Mutations – m.3243A>G

  • Associated with:
    • MELAS (mitochondrial encephalo-myopathy syndrome with lactic acidosis and cerebro-vascular accident episodes).
    • Maternally inherited diabetes with deafness.
    • Maternally inherited cardiomyopathy.
    • CPEO (chronic progressive external ophthalmoplegia).
  • Very diverse phenotypes, including disorders of the brain, ears, eyes, skeletal muscle, cardiac muscle, and metabolism.

MT-TL1 Gene - tRNA Leucine

  • Associated with specific mutations, like m.3243A>G
  • Factors:
    • Mutational load - variable within families.
    • Tissue distribution – muscle in CPEO, nerves in MELAS.
    • Threshold effect - certain tissues may be more susceptible to mitochondrial dysfunction than others.
    • Modifying factors – mitochondrial, nuclear, environmental.
  • Progression – sequential muscle biopsies show increased levels of mutant mtDNA.

Heteroplasmic and Homoplasmic Cells

  • Heteroplasmic cells: Contain a mixture of organelle DNA.
  • Homoplasmic cells: Carry only one type of organelle DNA.
  • Random partitioning of organelles during cell division is the basis of mitotic segregation.

Maternal Inheritance of MERRF

  • MERRF (myoclonic epilepsy and ragged red fiber disease) is maternally inherited.
  • Symptoms include uncontrolled jerking, muscle weakness, deafness, heart problems, kidney problems, and progressive dementia.
  • Pedigree analysis shows maternal inheritance and variations in the severity of symptoms.

Disease Phenotypes and mtDNA Ratio

  • Disease phenotypes reflect the ratio of mutant-to-wild-type mtDNAs and the reliance of cell type on mitochondrial function.
  • MERRF patient:
    • Heteroplasmic mitochondrial tRNA mutation.
    • Random partitioning.
    • Different tissues are affected differently.

Other Human Mitochondrial Diseases

  • Kearns-Sayre Syndrome (KSS):
    • Symptoms in eyes, muscles, heart, brain.
    • Deletion mutation in mtDNA.

mtDNA Deletion Syndromes

  • Three overlapping phenotypes:
    • Kearns-Sayre syndrome (KSS) – multisystem disorder, childhood onset, retinopathy, and ophthalmoplegia.
    • Pearson syndrome – sideroblastic anaemia, exocrine pancreas dysfunction, death in infancy.
    • CPEO – variable myopathy, ptosis, and ophthalmoplegia.
  • No specific region of mtDNA involved; at least one tRNA gene is deleted.
  • Usually flanked by short repeat sequences.
  • Usually de novo, rarely inherited.
  • Common deletion of 4977 base pairs.

Nuclear DNA Mutations

  • Deficiency of ETC – AR Leigh syndrome.
  • Deficiency of mtDNA maintenance – AD CPEO – POLG1.
  • mtDNA depletion syndrome – DGUOK – SUCLA2.

Key Understanding Points

  • Mitochondria, its genome, and role in energy metabolism within a cell.
  • Mitochondrial inheritance - Homoplasmy and Heteroplasmy, penetrance, significance of matrilineal (maternal) inheritance.
  • General categories of defects arising from mutations in mitochondrial genes (MERRF, MELAS, LHON etc.).
  • General categories of defects arising from mutations in nuclear genes that code for mitochondrial proteins.
  • Significance of the regulation of mitochondrial genes by nuclear proteins.